DK

Deepak Kulshreshtha

Active Director Director DIN 05176363
DIN 05176363 First appointment Jan 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2012
Shareholding value •••• Premium profile

About Deepak Kulshreshtha

Data last updated:

Deepak Kulshreshtha is a Director at Surmed Pharma Private Limited (since 2012). The company operates in Pharma. Surmed Pharma Private Limited reported revenue of ₹1.28 Cr (FY 2022).

DIN 05176363
Primary Designation Director
Industry Pharma
First Appointment 31 Jan 2012
Oldest Company Age 14 yrs
Largest company Surmed Pharma Private Limited · ₹1.28 Cr (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Surmed Pharma Private Limited U24233MP2012PTC027603
Director31 Jan 20122012₹1.28 Cr (FY 2022)Active

Board colleagues of Deepak Kulshreshtha

Directorship timeline

Open interactive timeline →
Surmed Pharma Private Limited
Premium access

Shareholding and investment profile for Deepak Kulshreshtha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepak Kulshreshtha

Deepak Kulshreshtha currently holds 1 directorship: Surmed Pharma Private Limited (Director, since 31 Jan 2012, revenue ₹1.28 Cr (FY 2022)).

Deepak Kulshreshtha was first appointed on 31 Jan 2012 as Director at Surmed Pharma Private Limited.

The current boards of Deepak Kulshreshtha's companies include Manoj Tandon (Surmed Pharma Private Limited), Subodh Kumar Shukla (Surmed Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available